Forge Biologics to Participate in Upcoming Investor Conferences and Presentations in March 2022

Designing for the Future of Cell and Gene Therapy Facilities






44 Thriving Biotech Startups (2021)






Current and Future Prospects for Gene Therapy for Rare Genetic Diseases Affecting the Brain and Spinal Cord






Solid Biosciences, Forge Biologics Enter Development and Manufacturing Pact






EMA Orphan Drug Designation for Forge Biologics’ gene therapy for Krabbe disease


VIDEO: Manufacturing Capabilities

